About Tangen Biosciences
Tangen Biosciences is a company based in Branford (United States) founded in 2013 by John Davidson.. Tangen Biosciences has raised $46.58 million across 13 funding rounds from investors including HHS, Connecticut Innovations and VC23. The company has 10 employees as of December 31, 2022. Tangen Biosciences operates in a competitive market with competitors including Great Basin Scientific, Hygiena, Aillis, HiberGene and Sanolla, among others.
- Headquarter Branford, United States
- Employees 10 as on 31 Dec, 2022
- Founders John Davidson
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Tangen Biosciences, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$46.58 M (USD)
in 13 rounds
-
Latest Funding Round
$464.77 K (USD), Series B
May 26, 2023
-
Investors
HHS
& 6 more
-
Employee Count
10
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Tangen Biosciences
Tangen Biosciences has successfully raised a total of $46.58M across 13 strategic funding rounds. The most recent funding activity was a Series B round of $464.77 thousand completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 13
- Last Round Series B — $464,767
-
First Round
First Round
(01 Jan 2014)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2023 | Amount | Series B - Tangen Biosciences | Valuation |
investors |
|
| Aug, 2020 | Amount | Series B - Tangen Biosciences | Valuation | Connecticut Innovations , VC23 |
|
| Jul, 2020 | Amount | Series B - Tangen Biosciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Tangen Biosciences
Tangen Biosciences has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Connecticut Innovations and VC23. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital services for biotech, IT, and innovative sectors in Connecticut.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in the life sciences sector
|
Founded Year | Domain | Location | |
|
Venture capital financing is offered to innovative entrepreneurs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Tangen Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Tangen Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tangen Biosciences Comparisons
Competitors of Tangen Biosciences
Tangen Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Great Basin Scientific, Hygiena, Aillis, HiberGene and Sanolla, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Chip-based molecular diagnostics for infectious diseases are commercialized.
|
|
| domain | founded_year | HQ Location |
Manufacturer of hygiene monitoring systems
|
|
| domain | founded_year | HQ Location |
Influenza is diagnosed using an AI-enabled medical device.
|
|
| domain | founded_year | HQ Location |
Develops and manufactures diagnostic tests for infectious diseases like meningitis.
|
|
| domain | founded_year | HQ Location |
AI-based digital diagnostics systems are developed for multiple disease detection.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Tangen Biosciences
Frequently Asked Questions about Tangen Biosciences
When was Tangen Biosciences founded?
Tangen Biosciences was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is Tangen Biosciences located?
Tangen Biosciences is headquartered in Branford, United States. It is registered at Branford, Connecticut, United States.
Is Tangen Biosciences a funded company?
Tangen Biosciences is a funded company, having raised a total of $46.58M across 13 funding rounds to date. The company's 1st funding round was a Series B of $11.24M, raised on Jan 01, 2014.
How many employees does Tangen Biosciences have?
As of Dec 31, 2022, the latest employee count at Tangen Biosciences is 10.
What does Tangen Biosciences do?
Tangen Biosciences was founded in 2013 in Branford, United States, within the biotechnology sector focused on diagnostics. A molecular diagnostics platform is developed, featuring the GeneSpark instrument for isothermal nucleic acid amplification to detect targeted DNAs and RNAs from specimens. The TangenDx assay, built on this platform, is applied to identify COVID-19, influenza, yeast, bacterial infections, and antimicrobial resistance in bloodstream cases. Operations center on advancing point-of-care testing solutions.
Who are the top competitors of Tangen Biosciences?
Tangen Biosciences's top competitors include Aillis, Great Basin Scientific and Hygiena.
Who are Tangen Biosciences's investors?
Tangen Biosciences has 7 investors. Key investors include HHS, Connecticut Innovations, VC23, Leading Edge Ventures, and Parvizi Surgical Innovation.